Bio + Health

(Engineered) Food. It’s What’s For Dinner.

Vijay Pande Posted January 24, 2020

The new discipline of bioengineering is going to dramatically impact how we produce and consume our food. The petroleum era ushered in many of the marquee companies and manufacturing processes of our generation – names such as IBM, BP and Texaco. But we are increasingly aware of the impact these processes have had on the environment. We know that we need to reinvent manufacturing to improve our planet and our health.

Bioengineering–which uses a range of approaches from electrical and mechanical engineering, computer and material sciences and, of course, biology–marks a shift in our ability to change nature itself. In 2020, we will see biology “eat” the manufacturing world. New companies will spring up to reinvent the processes by which our food is grown, made and distributed.

Biology is already being engineered to reinvent many of the food processes and products born out of the petroleum era. Take Apeel, which uses plant-derived technology to apply nature’s own protective “peel” material to fruits and vegetables, allowing them to last up to three times longer without refrigeration. This isn’t just about keeping your strawberries fresh; Apeel is revolutionizing logistics, as in many cases a cold chain is no longer needed, greatly decreasing cost and increasing optionality–and directly addressing worldwide food waste.

Other companies have engineered products such as non-browning apples, by editing the gene that causes the apple to brown. These kinds of products are better for consumers–and help our global systems by extending global trade routes, opening up new markets and reducing food waste on a global scale.

And of course we are seeing a move into plant-based “meat”. Companies such as Impossible Foods and Beyond Meat are already gaining traction with consumers. They have created an alternative to meat without the downsides of the traditional meat industry, such as methane production, consumption of grain, and E coli contamination. In 2020, we will see this industry shift further into bioengineered meat made directly from animal cells and requiring neither the birth nor slaughter of more animals.

This approach to manufacturing will spill over into many other food products. Dairy alternatives are already being produced in ways that don’t involve cows, from new plant products such as oat milk to milk products that can be grown in plants instead of secreted by cows. Fish, too, will also increasingly be grown from these techniques, helping to address problems such as overfishing, environmental concerns and toxic materials in our aquatic ecosystems.

These products, designed by humans using nature’s own processes, will be revolutionary in the impact they have on our global economies and the world’s health.

In 2020, the advances in bioengineering in academia and in industry mean that we will finally have the capability and technology to replace the world’s faulty systems.

Originally published in The WIRED World in 2020 © The Condé Nast Publications Ltd

Want More a16z Bio + Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Learn More

Want More Bio+Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Sign Up On Substack

Views expressed in “posts” (including podcasts, videos, and social media) are those of the individual a16z personnel quoted therein and are not the views of a16z Capital Management, L.L.C. (“a16z”) or its respective affiliates. a16z Capital Management is an investment adviser registered with the Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. The posts are not directed to any investors or potential investors, and do not constitute an offer to sell — or a solicitation of an offer to buy — any securities, and may not be used or relied upon in evaluating the merits of any investment.

The contents in here — and available on any associated distribution platforms and any public a16z online social media accounts, platforms, and sites (collectively, “content distribution outlets”) — should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here or on a16z content distribution outlets are for informational purposes only, and should not be relied upon when making any investment decision. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, posts may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. All content speaks only as of the date indicated.

Under no circumstances should any posts or other information provided on this website — or on associated content distribution outlets — be construed as an offer soliciting the purchase or sale of any security or interest in any pooled investment vehicle sponsored, discussed, or mentioned by a16z personnel. Nor should it be construed as an offer to provide investment advisory services; an offer to invest in an a16z-managed pooled investment vehicle will be made separately and only by means of the confidential offering documents of the specific pooled investment vehicles — which should be read in their entirety, and only to those who, among other requirements, meet certain qualifications under federal securities laws. Such investors, defined as accredited investors and qualified purchasers, are generally deemed capable of evaluating the merits and risks of prospective investments and financial matters.

There can be no assurances that a16z’s investment objectives will be achieved or investment strategies will be successful. Any investment in a vehicle managed by a16z involves a high degree of risk including the risk that the entire amount invested is lost. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/. Past results of a16z’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results. Excluded from this list are investments (and certain publicly traded cryptocurrencies/ digital assets) for which the issuer has not provided permission for a16z to disclose publicly. As for its investments in any cryptocurrency or token project, a16z is acting in its own financial interest, not necessarily in the interests of other token holders. a16z has no special role in any of these projects or power over their management. a16z does not undertake to continue to have any involvement in these projects other than as an investor and token holder, and other token holders should not expect that it will or rely on it to have any particular involvement.

With respect to funds managed by a16z that are registered in Japan, a16z will provide to any member of the Japanese public a copy of such documents as are required to be made publicly available pursuant to Article 63 of the Financial Instruments and Exchange Act of Japan. Please contact compliance@a16z.com to request such documents.

For other site terms of use, please go here. Additional important information about a16z, including our Form ADV Part 2A Brochure, is available at the SEC’s website: http://www.adviserinfo.sec.gov.